A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

Clinical trial NCT07412470 · RECRUITING

Trial details

NCT number: NCT07412470
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Kidney Transplant Rejection

Start date: 2026-03-13
Primary completion: 2029-08-15
Enrollment: 526

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.